Haemophilus influenzae Type B Antibody, IgG
Haemophilus influenzae (H. influenzae) is a Gram-negative, capnophilic coccobacillus commonly colonizing the upper respiratory tract. It can, however, invade and cause severe infections, including bacteremia, pneumonia, meningitis, acute otitis media, and epiglottitis, especially in unvaccinated children.
The pathogenicity of H. influenzae is significantly attributed to its polysaccharide capsule, which classifies it into six distinct types (a-f). Type B (Hib), characterized by the polyribosylribitol phosphate (PRP) capsule, is particularly virulent and responsible for more than 95% of severe invasive infections caused by H. influenzae.
Due to the immunogenic properties of Hib's PRP capsule, it is utilized in conjugate vaccines to induce protective immunity. Measurement of serum anti-Hib IgG antibodies is routinely employed to assess immune status post-vaccination and diagnose invasive Hib infections.
- As an aid in the diagnosis of invasive H. influenzae type B infections
- Useful in the monitoring of antibody levels following immunization
- Evaluation of immune status and protective antibody response post-Hib vaccination or infection
Protective Immunity: ≥ 15 mg/L (1.5 µg/mL)
Long-term Protective Immunity (post-vaccination, ≥3 weeks): ≥ 30 mg/L (3.0 µg/mL)
Enzyme Immunoassay (EIA).
Serum (SST tube).
Stability
- Ambient: 3-5 days
- Refrigerated: 7 days
- Frozen: 7 days
- Expert Rev Vaccines. 2020 Oct;19(10):903-917. [PMID: 32962476]
- Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S117-22. [PMID: 9781743]
- J Am Assoc Nurse Pract. 2015 Feb;27(2):114-9. [PMID: 24958314]
- J Fam Pract. 2000 Sep;49(9 Suppl):S7-13. [PMID: 11032188]